The N-terminal cytoplasmic region of NCBE displays features of an intrinsic disordered structure and represents a novel target for specific drug screening

• Published in: Frontiers in physiology Vol. 4; p. 320
• Main Authors: Bjerregaard-Andersen, Kaare, Perdreau-Dahl, Harmonie, Guldsten, Hanne, Praetorius, Jeppe, Jensen, Jan K, Morth, Jens P
• Format: Journal Article
• Language: English; Norwegian
• Published: Switzerland Frontiers Research Foundation 01.01.2013; Frontiers; Frontiers Media S.A
• Subjects: Biochemistry, Molecular Biology; CFTR; drug screen; intrinsic disorder; Life Sciences; NCBE; Physiology; slc26; SLC4; Structural Biology; bicarbonate; drug screen; IDP; NCBE; SLC4; intrinsic disorder
• ISSN: 1664-042X; 1664-042X
• DOI: 10.3389/fphys.2013.00320

The sodium dependent bicarbonate transporter NCBE/NBCn2 is predominantly expressed in the central nervous system (CNS). The highest protein concentrations are found in the choroid plexus. The primary function of this integral plasma membrane transport protein is to regulate intracellular neuronal pH and also probably to maintain the pH homeostasis across the blood-cerebrospinal fluid barrier. NCBE is predicted to contain at least 10 transmembrane helices. The N- and C- termini are both cytoplasmic, with a large N-terminal domain (Nt-NCBE) and a relatively small C-terminal domain (Ct-NCBE). The Nt-NCBE is likely to be involved in bicarbonate recognition and transport and contains key areas of regulation involving pH sensing and protein-protein interactions. Intrinsic disordered protein regions (IDPRs) are defined as protein regions having no rigid three-dimensional structure under physiological conditions. They are believed to be involved in signaling networks in which specific, low affinity, protein-protein interactions play an important role. We predict that NCBE and other SoLute Carrier 4 (SLC4) family members have a high level of intrinsic disorder in their cytoplasmic regions. To provide biophysical evidence for the IDPRs predicted in Nt-NCBE, we produced pure (>99%), recombinant Nt-NCBE using E. coli as the expression host. The protein was used to perform differential scanning fluorescence spectroscopy (DSF), in order to search for small molecules that would induce secondary or tertiary structure in the IDPRs. We expect this to assist the development of selective pharmaceutical compounds against individual SLC4 family members. We have also determined a low resolution (4 Å) X-ray crystal structure of the N-terminal core domain. The N-terminal cytoplasmic domain (cdb3) of anion exchanger 1 (AE1) shares a similar fold with the N-terminal core domain of NCBE. Crystallization conditions for the full-length N-terminal domain have been sought, but only the core domain yields diffracting crystals.